XOMA Royalty Declares Quarterly Preferred Stock Dividends
19 déc. 2024 07h30 HE
|
XOMA Royalty Corporation
XOMA Royalty January 2025 Dividend Record and Payment Dates
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
22 oct. 2024 08h00 HE
|
XOMA Corporation
XOMA Royalty acquires 50% economic interest in portfolio of 60-plus early-stage assets with $15M payment to Twist Bioscience
Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
23 sept. 2024 06h30 HE
|
XOMA Corporation
MIPLYFFA(TM) becomes 6th commercial asset in XOMA Royalty's portfolio
XOMA Declares Quarterly Preferred Stock Dividends
20 juin 2024 07h30 HE
|
XOMA Corporation
July 2024 Dividends
XOMA Corporation Announces Closing of Tender Offer
03 avr. 2024 09h00 HE
|
XOMA Corporation
XOMA completes acquisition of Kinnate.
XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
16 févr. 2024 08h00 HE
|
XOMA Corporation
XOMA enters agreement to acquire Kinnate for cash and CVR; Expects to add $9.5M cash to balance sheet upon completion of acquisition
FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx
11 janv. 2024 16h05 HE
|
XOMA Corporation
EMERYVILLE, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today that based upon the U.S. Food and Drug Administration’s (FDA)...
XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors
08 janv. 2024 07h30 HE
|
XOMA Corporation
XOMA appoints Owen Hughes as CEO
XOMA Declares Quarterly Preferred Stock Dividends
20 déc. 2023 07h30 HE
|
XOMA Corporation
January quarterly dividend payment to XOMAP and XOMAO stockholders of record on 1/3/2024
XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio
30 mars 2023 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today it has acquired the commercial payment and a portion of the milestone rights to IXINITY®...